Clinical communications specialist Feedback has been awarded two 12-month contracts to provide its flagship product ‘Bleepa’ across two NHS trusts, it announced on Friday, for a total value of £0.2m.
The AIM-traded firm said the first contract followed a successful pilot and co-development on the platform over the last two years, representing the first full-cycle realisation of its pilot-to-contract business model.
It said the second contract was a renewal, following the success of an initial one-year contract, at a higher value than the initial contract.
“We are delighted to see the value of Bleepa as a core clinical system recognised through the award of two customer contracts,” said chief executive officer Tom Oakley.
“Over the last year we have significantly grown the number of Bleepa users and it is good to see this growth recognised in the uplift in contract value achieved.
“These contracts are early evidence of the success of our 2019 strategic shift.”
At 1224 BST, shares in Feedback were up 7.02% at 0.72p.
